Why Chewy Stock Is Sinking This Week

Chewy (NYSE: CHWY) shares declined 15% this week after the online pet goods retailer issued conservative Q3 guidance, projecting 7.5% sales growth and $0.30 adjusted EPS, despite reporting strong Q2 results with a 9% sales increase and 38% rise in adjusted EPS. Operationally, Chewy shows significant strength, with recurring autoship sales accounting for 83% of total revenue, and is strategically expanding into higher-margin verticals such as sponsored ads, a membership program, private-label fresh food, and veterinary clinics, positioning the company for potential long-term profit growth despite the short-term guidance-driven sell-off.

Analysis

Chewy's (CHWY) stock experienced a significant 15% decline this week, a market reaction directly tied to the company's conservative Q3 guidance, which projects 7.5% sales growth and an adjusted EPS of $0.30. This forward-looking caution contrasts sharply with the firm's robust second-quarter performance, where it delivered a 9% increase in sales and a 38% rise in adjusted EPS. Operationally, the company demonstrates considerable strength, underscored by a 15% growth in autoship sales, which now constitute a highly stable and predictable 83% of total revenue. Furthermore, Chewy is actively executing a strategy to enhance profitability by expanding into higher-margin verticals. Key initiatives already showing traction include sponsored advertisements, which contributed to a 90-basis-point rise in gross margin, and a new membership program, Chewy+, which accounted for 3% of sales in July. Future margin expansion is expected to be driven by the launch of a private-label premium food brand and the establishment of 20 Chewy Vet Care locations by year-end, positioning the company to capture more value from the pet care ecosystem despite the market's current pessimism on its short-term growth trajectory.

Key Decisions for Investors

• Investors with a long-term outlook could view the 15% stock drop, driven by conservative guidance, as a potential entry point, given the disconnect between short-term sentiment and strong underlying business fundamentals.
• Closely monitor the financial contribution from new higher-margin initiatives, particularly sponsored ad revenue, Chewy+ membership growth, and the performance of the new Vet Care clinics, as these are the primary catalysts for the thesis of future profit growth.
• Acknowledge the near-term risk that the stock may remain under pressure if the company fails to beat its own conservative Q3 guidance, as the market has clearly shown its sensitivity to decelerating growth forecasts.
• Evaluate the stock’s valuation at 29 times forward earnings against the successful execution of its margin-expansion strategy, which could justify a premium if a clear path to higher profitability is demonstrated in coming quarters.